| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0056 | 1 |